Yusuke Ogoshi
Okayama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Ganetespib in Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-resistant Non-small Cell Lung Cancer.
Journal: Anticancer research
Published: February 08, 2019
Acquired resistance mechanisms to afatinib in HER2-amplified gastric cancer cells.
Journal: Cancer science
Published: January 31, 2019
Application of amplicon-based targeted sequencing with the molecular barcoding system to detect uncommon minor EGFR mutations in patients with treatment-naïve lung adenocarcinoma.
Journal: BMC cancer
Published: August 18, 2018
Anti-tumor effect of neratinib against lung cancer cells harboring HER2 oncogene alterations.
Journal: Oncology letters
Published: June 27, 2018
Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR-Mutant Non-Small Cell Lung Cancer Cells.
Journal: Molecular cancer research : MCR
Published: June 13, 2018
Newly developed anti-S100A8/A9 monoclonal antibody efficiently prevents lung tropic cancer metastasis.
Journal: International journal of cancer
Published: May 27, 2018
exSSSRs (extracellular S100 soil sensor receptors)-Fc fusion proteins work as prominent decoys to S100A8/A9-induced lung tropic cancer metastasis.
Journal: International journal of cancer
Published: April 26, 2018
Comparative mutational evaluation of multiple lung cancers by multiplex oncogene mutation analysis.
Journal: Cancer science
Published: April 19, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026